SCHEMBL23567258

SCHEMBL23567258

C#CCCCCCCOCOCCCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
THRB P10828 2/20 0.42
CES2 O00748 2/20 0.39
ALDH1A1 P00352 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
USP2 O75604 1/20 0.37
CES1 P23141 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 2/20 0.34
RAB9A P51151 2/20 0.34
GAA P10253 1/20 0.34
SPHK1 Q9NYA1 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23567255 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567222 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567308 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567221 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567265 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567267 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567288 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567280 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567225 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB
SCHEMBL23567264 1.00 HTT (0.42) HTTMAPTMEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113024359-B Process for preparing alkoxymethyl alkynyl ether compounds having terminal triple bonds 信越化学工业株式会社 2024-06-11 CN disclosed
EP-3842406-B1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND SHINETSU CHEMICAL CO (JP) 2023-10-11 EP disclosed
US-11384041-B2 Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-07-12 US disclosed
US-20210198172-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-01 US disclosed
EP-3842406-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND Shin-Etsu Chemical Co., Ltd. (JP) 2021-06-30 EP disclosed
CN-113024359-A Method for producing alkoxymethyl alkynyl ether compounds having terminal triple bond 信越化学工业株式会社 2021-06-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198172-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND CBR3, CBR1, AOC2 HTT 3236/4885MAPT 4691/4885MEN1 4017/4885
US-11384041-B2 Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond CBR3, CBR1, AOC2 HTT 3236/4885MAPT 4691/4885MEN1 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.